| Gottardi, Michele |
| Recruiting | 3 | 414 | Europe | Gemtuzumab Ozogamicin | Gruppo Italiano Malattie EMatologiche dell'Adulto, Fondazione GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) Franco Mandelli Onlus, Pfizer S.R.L. | Acute Myeloid Leukemia | 04/25 | 04/27 | | |
INO-CD22, NCT03898128: ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate |
|
|
| Recruiting | N/A | 120 | Europe | Anti-CD22 Immunotoxin | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | Acute Lymphoblastic Leukemia | 06/21 | 09/21 | | |
NCT03789981: Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia |
|
|
| Active, not recruiting | N/A | 75 | Europe | Immunogenic profile | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | Acute Myeloid Leukemia | 12/24 | 12/25 | | |
NCT04460963: Role of Adrenomedullin in Leukemic Endosteal/Vascular Niches |
|
|
| Recruiting | N/A | 72 | Europe | Adrenomedullin | Gruppo Italiano Malattie EMatologiche dell'Adulto | Acute Myeloid Leukemia | 06/24 | 06/24 | | |
NCT06600568: Novel Therapeutic Approach for Human T-cell Malignancies |
|
|
| Recruiting | N/A | 120 | Europe | Translation analysis | Istituto Oncologico Veneto IRCCS, Istituto Nazionale Tumori IRCSS-Fondazione G.Pascale | T-Cell Leukemia/Lymphoma, Adult | 07/26 | 07/26 | | |
INTHEMA, NCT04298892: Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies |
|
|
| Recruiting | N/A | 2000 | Europe | clinical data and sample collection | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori, Azienda Unità Sanitaria Locale della Romagna | Haematologic Disease, Haematological Malignancy | 02/25 | 02/25 | | |
